|
⚲
|
| Keyboard |
| Acorn Capital Advisors LLC
✚
|
|
|---|---|
| CRD # | 304164 |
| SEC # | 801-120833 |
| CIK # | 0002054410 |
| AUM | 355.3 M (2026-03-19) |
| Employees | 5 (100% Investors, 0% Brokers) |
| Phone | 212-299-4777 |
| Address | 420 Lexington Avenue New York, NY 10170 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($M) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| CG Oncology Inc | 76.6 | ||
| UroGen Pharma Ltd | 30.1 | ||
| Innovative Acquisitions Corp | 26.4 | ||
| Trevi Therapeutics Inc | 25.6 | ||
| Candel Therapeutics Inc | 17.2 | ||
| Bicara Therapeutics Inc | 12.8 | ||
| Reneo Pharmaceuticals Inc | 11.8 | ||
| Aerovate Therapeutics Inc | 11.1 | ||
| Proteon Therapeutics Inc | 9.1 | ||
| Verastem Inc | 7.8 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| VC | Acorn BioVentures 2 LP | [2022-03-11] | 195.4 M | |
| Filed 2021-12-02 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Acorn BioVentures LP | [2019-05-06] | 199.5 M | 159.9 M |
| Filed 2020-03-27 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 2 | 355.3 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 2 | 355.3 |
| By Discretionary | ||
| Discretionary | 2 | 355.3 |
| Non-Discretionary | 0 | 0.0 |
| Total | 2 | 355.3 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 355.3 | |
| Total | 2 | 355.3 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Anders Hove | Promoter | 16 | 4 | |
| General Partner Acorn Capital Advisors GP LLC | Promoter | 1 | 1 | |
| General Partner Acorn Capital Advisors GP 2 LLC | Promoter | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0002054410] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Private Equity |
| Comparable Firms | State | AUM |
|---|---|---|
|
C Cubed Capital Partners LLC
✚
|
FL | 362.7 M |
|
Round Table Capital Management LP
✚
|
FL | 362.4 M |
|
Kanbrick LLC
✚
|
NC | 362.2 M |
|
Arkview Capital LP
✚
|
CT | 355.9 M |
|
Next Management Advisors LLC
✚
|
NY | 353.1 M |
|
10Talents Investors LLC
✚
|
MA | 353.0 M |
|
CPC Equity Advisors LP
✚
|
CA | 352.2 M |
|
Forman Capital LLC
✚
|
FL | 350.5 M |
|
Willis Asset Finance Management LLC
✚
|
FL | 349.0 M |
|
I Squared Capital Registered Advisor LLC
✚
|
FL | 348.1 M |